SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH)

China · Delayed Price · Currency is USD
2.53-0.04 (-1.56%)
 
Market Cap1.89M-98.6%
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out747.90K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume100,593.326
Open2.40
Previous Close2.57
Day's Range2.38 - 2.96
52-Week Range1.90 - 188.00
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a
-1.56% (1D)
No price history available.
Insider Score
––Not scored
BYAH Insider Score

Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About BYAH

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service. The company offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company has a strategic partnership with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach. Park Ha Biological Technology Co., Ltd. has strategic partnership with Cloud Factory Technology Holdings Limited to build ai-driven ecosystem for the beauty industry. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Address
Building C, Wuxi, 214100, China
Market Cap
2 million
Employees
41
Industrial Classification
Household & Personal Products
1 Day
+0.97%
5 Days
+14.32%
1 Month
+14.32%
6 Months
-69.11%
1 Year
-98.61%

$BYAH stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BYAH holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BYAH's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BYAH Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New BYAH patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BYAH from public contracts

Source: USAspending.gov

BYAH Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for BYAH yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from BYAH’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.